Stopping Clonazepam or Alprazolam: Why Cold Turkey Fails and What a Proper Taper Looks Like

By Dr. Anindo Mitra | MBBS, MD Psychiatry (JIPMER) | Consultant Psychiatrist, Athena Behavioural Health, Gurugram

TL;DR

• Clonazepam and alprazolam are among the most commonly prescribed benzodiazepines in India — often without a clear exit plan

• Physical dependence on benzodiazepines is a neurological process, not a character flaw

• Stopping abruptly is medically dangerous and can cause seizures, not just discomfort

• A proper taper — slow, individualised, supervised — is the only safe way off

• Recovery is possible; most people do get through it with the right support

Introduction

If you are reading this, you or someone you know is probably on clonazepam or alprazolam — possibly for longer than was originally intended. Maybe it started as a two-week prescription for anxiety or sleep. Maybe it was prescribed alongside an antidepressant and nobody revisited it. Maybe you have been on it for two years, and every time you try to stop, things get worse.

That experience is not unusual. In India, a large multicentric study by Grover et al. published in the Indian Journal of Psychiatry found that more than two-thirds of psychiatric outpatients across all diagnostic categories were prescribed a benzodiazepine — clonazepam being the most commonly prescribed agent. Co-prescription with antidepressants was frequent, often without a documented plan for discontinuation.

This post is not about blame — not toward prescribers, not toward patients. Long-term benzodiazepine use happens for reasons that are clinically understandable. What matters now is what comes next.

Why Clonazepam and Alprazolam Are Not Like Other Anxiety Medications

Clonazepam and alprazolam belong to a class of drugs called benzodiazepines. They work by enhancing the effect of GABA — the brain's primary inhibitory neurotransmitter — at specific receptor sites. The result is rapid sedation, muscle relaxation, and anxiety relief. For acute situations, this is exactly what is needed.

The problem develops with regular use over weeks to months. The brain responds to consistent GABA enhancement by downregulating its own GABA receptors — essentially reducing its sensitivity to its own calming system. This is the neurological basis of tolerance and dependence. It is not a personality trait. It is biology.

Alprazolam (brand name Xanax/ Alprax, widely available in India) has a shorter half-life than clonazepam, which means it leaves the body faster. This makes it more reinforcing — the anxious feeling returns sooner, which drives more frequent dosing — and withdrawal symptoms can begin within hours of a missed dose. NICE Guideline NG215 notes that short-acting benzodiazepines carry a higher dependence liability than longer-acting agents.

Clonazepam has a longer half-life (20–50 hours), which means it stays in the body longer and withdrawal symptoms emerge more gradually — sometimes days after the last dose. This can make dependence less obvious and easier to miss clinically.

What Happens When You Stop Abruptly

Stopping clonazepam or alprazolam suddenly — without a taper — is not just uncomfortable. It can be dangerous.

When the brain has downregulated its GABA system to compensate for the drug, removing the drug suddenly leaves the inhibitory system severely depleted. The excitatory system (glutamate) takes over, essentially unopposed. This produces what clinicians call benzodiazepine withdrawal syndrome.

Symptoms of benzodiazepine withdrawal can include:

• Intense anxiety, panic attacks, and agitation (often worse than the original anxiety the drug was prescribed for)

• Insomnia, nightmares, vivid dreams

• Tremors, sweating, palpitations

• Sensitivity to light, sound, and touch

• Depersonalisation — a sense of unreality or detachment

• Seizures

The last point deserves emphasis. StatPearls notes that benzodiazepine and alcohol withdrawal are in the same medical risk category— both potentially life-threatening, both capable of causing seizures without proper management.

Seizures from benzodiazepine withdrawal are not a remote theoretical risk. They happen. This is why "just stopping" is not a reasonable clinical plan.

Why Withdrawal Feels Like Relapse (and Why That Matters)

One of the most distressing aspects of benzodiazepine withdrawal is that the symptoms closely resemble the original anxiety disorder. When someone stops clonazepam and experiences a sudden flood of panic, insomnia, and racing thoughts, it is very easy — for the patient and sometimes for clinicians — to interpret this as proof that the medication is necessary.

This is a critical distinction that I cover in more detail in a separate post: Withdrawal or Relapse: How to Tell the Difference — but the short version is this: withdrawal symptoms peak early (within days of stopping or reducing) and then gradually improve over weeks, whereas relapse of an anxiety disorder tends to be slower in onset and does not resolve on its own without treatment.

Misidentifying withdrawal as relapse leads to a predictable outcome: the medication is restarted, the patient is told they need it indefinitely, and no further attempt is made to taper.

The Indian Context: Why This Problem Is Larger Than We Acknowledge

Benzodiazepine availability in India creates a specific clinical challenge. Clonazepam (sold under brands like Rivotril/Petril) and alprazolam (Restyl, Alprax, and others) are Schedule H drugs — meaning they require a prescription — but enforcement of prescription requirements is inconsistent, particularly in smaller pharmacies. Patients can and do obtain refills without reconsultation.

This, combined with the finding in Grover et al.'s IPS multicentric study that clonazepam was prescribed to over two-thirds of patients across diagnostic categories, means there is likely a substantial population of people using these medications chronically without a clear clinical plan for stopping.

A 2014 multicentric study across 11 Indian centres found clonazepam was prescribed approximately five times more commonly than lorazepam as an anxiolytic. The reasons are partly pharmacological (longer half-life, once-daily dosing) but also reflect prescribing habits that have become entrenched without equivalent attention to deprescribing pathways.

None of this is said to alarm. It is context. Understanding that long-term benzodiazepine use is a structural problem — not a personal one — matters for reducing the shame that often stops people from asking for help.

What a Proper Taper Actually Involves

A supervised benzodiazepine taper is not a fixed protocol. It is an individualised plan shaped by the specific drug, the dose, how long someone has been on it, their clinical history, and their life circumstances.

The general principles, drawn from NICE Guideline NG215 on medicines associated with dependence, include:

1. Switch to a longer-acting equivalent where necessary. For people on alprazolam (short half-life), many clinicians switch to diazepam before beginning a taper. Diazepam's long half-life (20–100 hours) produces more stable blood levels, making withdrawal symptoms more manageable. The dose equivalence is approximately: 0.5 mg alprazolam = 10 mg diazepam.

2. Reduce slowly — much more slowly than most people expect. A common starting rate is a 5–10% reduction of the current dose every 2–4 weeks. This is not a typo. For someone on clonazepam 2 mg daily, this means reductions of 0.1–0.2 mg at a time. Rapid tapers (over 2–4 weeks) consistently produce worse outcomes than slow ones.

3. Hold, don't rush. If withdrawal symptoms at a given step are intolerable, the correct response is to hold at the current dose until symptoms settle — not to push through or to give up entirely. Progress is not linear.

4. The final steps are often the hardest. Counterintuitively, the last small doses of a benzodiazepine can be the most difficult to stop. The body has become sensitised at low levels. This is normal, and knowing it in advance prevents people from concluding that they can never get off.

5. Psychological support matters. CBT specifically adapted for anxiety disorders significantly improves taper outcomes. A meta-analysis in the Journal of Psychiatric Research found that patients who combined CBT with a gradual taper were nearly twice as likely to be benzodiazepine-free at 6–12 months compared to those on taper alone.

What to Expect: A Realistic Timeline

There is no universal timeline. Someone who has been on clonazepam 0.5 mg daily for six months will have a different experience from someone on 2 mg daily for five years.

Rough reference points:

• Short-term users (under 6 months): Taper may take 4–8 weeks. Withdrawal symptoms are generally manageable.

• Moderate-term users (6 months–2 years): Taper typically takes 3–6 months. Some protracted symptoms may persist beyond the last dose.

• Long-term users (over 2 years, or high doses): Taper may take 6–18 months or longer. Protracted withdrawal syndrome — where low-level symptoms persist for months after stopping — is more common and requires ongoing support.

These are reference points, not predictions. Individual variation is wide.

A Note on Alprazolam Specifically

Alprazolam deserves specific mention because it is widely prescribed in India and has a higher dependence liability than clonazepam due to its shorter half-life and more rapid onset of action. It has been the subject of specific clinical concern in addiction psychiatry literature.

Patients on alprazolam often describe a distinct "wearing off" effect between doses — rising anxiety as the drug exits the system, which drives the next dose. This is interdose withdrawal, and it is a pharmacological phenomenon, not anxiety returning. Over time, dosing intervals shorten and doses increase. Many people who come to clinic on high doses of alprazolam started on a standard 0.25 mg or 0.5 mg dose.

If you are on alprazolam and notice that you need it more frequently to feel the same effect, or that you feel anxious or physically unwell between doses, this is worth discussing with your psychiatrist. It is a signal that dependence has developed and a structured plan is needed.

Conclusion

Stopping clonazepam or alprazolam without a plan is not courage. It is a medical risk. The brain needs time to restore its own regulatory systems, and attempting to rush that process causes harm.

Getting off benzodiazepines is possible. Many people do it successfully with appropriate support. The prerequisites are an honest conversation with a psychiatrist, a realistic timeline, psychological support where possible, and patience with a process that does not move quickly.

If you are currently on a benzodiazepine and thinking about stopping, do not stop before speaking with your prescribing doctor. If you have already tried to stop and found it impossible alone, that does not mean you cannot do it — it means you need a proper taper, not willpower.

Explore More in This Series

This post is part of the Deprescribing series on dranindomitra.com:

• Withdrawal or Relapse: How to Tell the Difference (coming soon)

• Am I Ready to Stop My Antidepressant? A Psychiatrist's Checklist (coming soon)

• Are Psychiatric Medications Addictive? The Honest Answer (coming soon)

• How Long Should You Actually Be on a Psychiatric Medication? (coming soon)

Or visit the Deprescribing overview page for the full picture.

Dr. Anindo Mitra is a Consultant Psychiatrist at Athena Behavioural Health, Gurugram. He completed his MD in Psychiatry from JIPMER, Puducherry. His clinical interests include rational psychopharmacology, deprescribing, and the long-term management of anxiety and mood disorders.

This post is for educational purposes only. It does not constitute individualised medical advice. If you are considering stopping any psychiatric medication, please consult your treating psychiatrist.

FAQ

Q: Is it normal to feel worse when I reduce my clonazepam?

Yes. Some increase in anxiety and sleep disturbance when reducing a benzodiazepine is expected — this is withdrawal, not your original condition returning. The key question is the timeline: withdrawal symptoms tend to peak within days of a dose reduction and then settle. If symptoms persist or worsen beyond a few weeks at the same dose, speak with your psychiatrist about slowing the taper.

Q: My doctor told me I could just stop clonazepam after two weeks. Is that accurate?

For a short course (2–4 weeks) at a low dose, some patients can stop without a formal taper, though a gradual reduction is still advisable. For anyone who has been on a benzodiazepine for more than 4–6 weeks, a structured taper is the safer approach. Duration and dose both matter.

Q: Can I switch from alprazolam to diazepam on my own?

No. Dose equivalence between benzodiazepines is approximate and varies between individuals. A switch should only be done under medical supervision, with monitoring during the transition. Do not attempt this without a prescription and clinical oversight.

Q: What is protracted withdrawal syndrome?

Some people who have been on benzodiazepines for many years experience a prolonged period of low-level symptoms after stopping — including anxiety, poor sleep, cognitive fog, and emotional blunting — that can persist for months. This is protracted withdrawal syndrome and does not mean the brain is permanently damaged. Most people recover fully, though the timeline varies. Ongoing psychiatric and psychological support during this period is important.

Q: Are there medications that help with the taper?

The primary medication used in benzodiazepine tapering is the benzodiazepine itself, reduced slowly. In some cases, adjunctive agents — such as propranolol for physical symptoms, or certain antidepressants — may be used. There is no medication that safely replaces a benzodiazepine during withdrawal without its own risks. Gabapentin and pregabalin are sometimes used but have their own dependence potential. All of this should be discussed with your psychiatrist.

Q: Can I get off benzodiazepines if I have been on them for five years?

Yes. Long duration makes the taper slower — likely measured in months rather than weeks — and increases the chance of protracted symptoms, but it does not make stopping impossible. Many patients do get off long-term benzodiazepine use successfully with a structured plan and appropriate support.